Loading clinical trials...
Loading clinical trials...
Prostasin Levels in Preeclampsia: A Comparative Study With Healthy Pregnancies
This study will aim to compare maternal serum prostasin levels between women diagnosed with preeclampsia and healthy normotensive pregnant controls. Participants will be divided into two main groups: those with preeclampsia and those with uncomplicated pregnancies. The preeclampsia group will further be subdivided based on the severity of the condition. Maternal serum samples will be collected from all participants, and prostasin levels will be measured using ELISA. Statistical analyses will be performed to evaluate whether prostasin levels are significantly elevated in the preeclampsia group, particularly in those with severe features, and to assess its potential as a biomarker for the condition.
Age
18 - 40 years
Sex
FEMALE
Healthy Volunteers
Yes
Cam and Sakura City Hospital
Istanbul, Turkey (Türkiye)
Start Date
January 1, 2023
Primary Completion Date
January 1, 2024
Completion Date
March 1, 2024
Last Updated
October 2, 2024
88
ACTUAL participants
Lead Sponsor
Başakşehir Çam & Sakura City Hospital
NCT06408181
NCT06821685
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04520048